"My Non-random Walk from Ph.D. to C.E.O. in Digital Health"
Deborah Kilpatrick, Ph.D.
Chief Executive Officer
Deborah Kilpatrick, Ph.D., is the C.E.O. of Evidation Health, a digital health company. Evidation Health is focused on creating digital health product value through clinical and economic outcomes and predictive analytics that help providers deploy the most effective interventions for the right patients at the right time. Prior to her role at Evidation Health, Deborah was the Chief Commercial Officer of the genomic diagnostics company CardioDx, whose Corus CAD product was named in the Wall Street Journal Technology Innovation Awards, TIME Magazine's Top 10 Medical Breakthroughs, and the Edison Awards. Earlier in her career, Deborah held multiple leadership roles at Guidant Corporation, including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division. She serves on the Georgia Tech Advisory Board and the Board of Directors for the Dystonia Medical Research Foundation and is a Fellow of the American Institute of Medical and Biological Engineering. Deborah is a co-founder of the MedtechVision Conference now held annually in Silicon Valley, and in 2013 she was named to FierceBiotech’s list of the Top Women in Biotech as well as Silicon Valley Business Journal’s 100 Women of Influence list. She holds B.S., M.S. and Ph.D. degrees in mechanical engineering with a bioengineering focus from Georgia Tech.
This seminar is hosted by the Bioengineering and Bioscience Unified Graduate Students (BBUGS) Industry Committee and the Parker H. Petit Institute for Bioengineering and Bioscience.